DREAMM5

Platform Study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination with Anti-Cancer Treatments in Participants with Relapsed/Refractory Multiple Myeloma (RRMM)

Near Add Your Location

Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients
  • Show Principal Investigator
University of Wisconsin - Carbone Cancer Center
University of Wisconsin Health
Madison, WI
  • Accepting patients
  • Show Principal Investigator
Get personalized results in 60 seconds
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials
Dana-Farber Cancer Institute
Boston, MA
  • Accepting patients
  • Show Principal Investigator
Scripps Green Hospital
San Diego, CA
  • Not yet accepting
  • Show Principal Investigator
Simon Cancer Center
Indiana University
Indianapolis, IN
  • Accepting patients
  • Show Principal Investigator
MD Anderson Cancer Center
The University of Texas
Houston, TX
  • Not yet accepting
  • Show Principal Investigator
Princess Margaret Cancer Centre
University Health Network
Old Toronto, ON
  • Accepting patients
University of British Columbia
UBC Hospital
Vancouver, BC
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.